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Abstract 
Background Ethnic minorities with Type 1 Diabetes (T1D) have worse glycaemic control (higher HbA1c) and 
greater risk for vascular complications. There is limited evidence on the impact of ethnicity on early 
glycaemic control when patients experience transient remission post-diagnosis. We used modelling 
techniques to examine the independent contribution of ethnicity on HbA1c trajectories during the first six 
months post-diagnosis.  
Methods Data on 443 (50% female) children <19years of age, with T1D and attending one of three clinics in 
East London between Jan 2005 and Dec 2015 were included. Linear mixed-effects modelling was used to 
assess effects of ethnicity on longitudinal HbA1c trajectories during first six months post-diagnosis (1,028 
HbA1c datapoints), adjusting for sex, age at diagnosis, socioeconomic status and pH at diagnosis. Growth 
curve modelling was used to identify discrete HbA1c trajectories by ethnicity.   
Results All ethnic minorities had higher mean HbA1c at diagnosis compared to White children, most marked 
in Bangladeshi (9.7mmol/mol, 95% CI 5.1-14.3), Asian-Other (5.8mmol/mol, 95% CI 2.2-9.3) and Somali 
(5.2mmol/mol, 95% CI 0.1-10.2) children. During the first month, HbA1c decreased on average by 
19.5mmol/mol (-21, -18) for all children. Population averaged HbA1c decreased between diagnosis and four 
months, followed by a gradual increase in HbA1c levels (mean difference of -30mmol/mol between 
diagnosis and six months). All ethnic groups had higher HbA1c levels throughout this time period compared 
to White children. 
Conclusions Ethnic minorities have worse glycaemic control at diagnosis, with largest mean differences in 
Bangladeshi, Asian-Other and Somali children. These higher levels track into the first six months post-
diagnosis.  
Keywords Ethnicity, Socioeconomic status, child, type 1 diabetes, glycaemic control, HbA1c 
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Introduction 
 
Inequalities in paediatric type 1 diabetes (T1D) outcomes are well recognised. Children and young people 
(CYP) of lower socioeconomic status (SES) and ethnic minorities tend to have poorer glycaemic control and 
increased risk for acute life threatening complications (diabetic ketoacidosis and hypoglycaemia) and 
chronic vascular complications in later life (1-3). In a recently published study using national data on >95% 
of CYP with T1D in England and Wales, we found that all ethnic minorities had poorer glycaemic control 
(higher blood glycosylated haemoglobin [HbA1c] concentrations) compared to White CYP (4). Lower SES 
was associated with poor glycaemic control in all ethnic groups but being poor and ethnic minority had 
significantly worse impact on glycaemic control than being poor and White.  
 
Studies show that young patients from lower SES and ethnic minority backgrounds receive a later diagnosis 
of T1D and present with significantly worse symptoms at diagnosis (greater severity of diabetic ketoacidosis 
and higher HbA1c levels) (5, 6). A greater level of metabolic derangement at diagnosis may reflect factors 
such as poorer/late access to medical care (5, 7), cultural and/or biological differences between ethnic 
groups [ref] and also a lower level of residual pancreatic beta-cell function (8). There have been reports on 
associations between clinical presentation at diagnosis and subsequent early glycaemic control (9).  
Therefore if ethnic minorities present with worse clinical factors at diagnosis, one could hypothesise that 
the stabilisation of glycaemic control during the period of transient remission (‘honeymoon phase’) 
experienced by most newly diagnosed T1D patients, could also differ by ethnic background (10). However, 
this has not been comprehensively investigated in a multi-ethnic population in the UK. This is especially 
important to study as early glycaemic control during the first year post-diagnosis is linked to subsequent 
future control which may track into adulthood (11).   
 
In order to identify those groups of CYP with poor glycaemic control based on clinical factors at 
presentation, we investigated ethnic differences in stabilisation of glycaemic control during the first six 
months post-diagnosis in a multi-ethnic population attending diabetes clinics in East London. Identification 
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of patients with initial and subsequent poor glycaemic control could help in devising targeted policies to 
help these CYP have better outcomes in the future.  
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Methods 
 
Design, setting and data source  
 
We undertook a longitudinal cohort study of newly diagnosed patients with type 1 diabetes using data from 
three paediatric diabetes clinics that are part of the same Healthcare Trust (Barts Health NHS Trust) and 
located in East London, UK. The three clinics largely capture patients living in surrounding areas of East 
London, where up to 56% of the local population belongs to an ethnic minority with c. 50% of South Asian 
origin (primarily of Bangladeshi origin) and c. 40% of Black origin (primarily of Somali origin).  
 
The study was restricted to children <19 years of age who received a diagnosis of type 1 diabetes between 
1 Jan 2005 and 31 Dec 2015 and attended any one of the three clinics during the same period. Extensive 
clinical and sociodemographic data was collected prospectively, both at the time of diagnosis and during 
routine clinic visits. As per previous and current recommendations from the National Institute of Health and 
Care Excellence (NICE), a child with Type 1 diabetes is offered an integrated package of care by a 
multidisciplinary team at a paediatric diabetes clinic four times per year. The team consists of paediatric 
endocrinologists/diabetologists, diabetes specialist nurses, dieticians, psychologists and interpreters. HbA1c 
levels and height and weight are recorded at each visit. All demographical and clinical parameters are 
measured and electronically documented systematically across all three clinics enabling comparison. Out of 
596 children diagnosed with type 1 diabetes during the study period, 571 (96%) children had data on sex, 
age at diagnosis, duration of diabetes, ethnicity and SES and were eligible to be included in the analysis. 
 
Primary outcome, exposures and covariates 
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The outcome of interest was glycaemic control measured by HbA1c levels. HbA1c was measured at each 
visit using the point of care Siemens/Bayer DCA 2000+ Analyzer. HbA1c values recorded as percentages 
were converted to mmol/mol using the formula: (HbA1c value in % – 2.15) × 10.929.  
 
The main exposures of interest were ethnicity and SES. Participants (or their parents) were asked to self-
identify their ethnicity when they visited a clinic and we used the first recorded entries for ethnicity at the 
time of diagnosis. They were given the option to choose 1 of 15 categories or also the option to decline 
identifying their ethnicity. For the purpose of this study, the 15 ethnic categories were collapsed into six 
broad groups: White, mixed (any mixed ethnicity combination), Black, African-Somali, Bangladeshi and 
Asian-other (any Asian origin excluding Bangladeshi) which reflects the ethnic distribution of the study area 
in East London. The latter group included CYP mostly of Indian or Pakistani origin and a much smaller 
proportion originating from other Asian countries. The pH value (blood capillary samples) measured closest 
to initial presentation was used in the analysis.  
 
SES was derived from postcode using Indices of Multiple Deprivation (IMD) 2010 for England. The IMD is a 
small geographical area measure of deprivation. It is multidimensional and scores are derived from a 
weighted combination of several indicators across seven distinct measures of deprivation including: 
income, employment, education skills and training, health, barriers to housing and services, living 
environment and crime [21]. It captures the ‘relative’ deprivation experienced by an individual living in an 
area. IMD scores are calculated at the level of lower-layer super output areas, with each area comprising 
1500 individuals on average. IMD rank scores were grouped into quartiles for the analysis, with the first and 
fourth quartiles corresponding to the most and least deprived, respectively. 
 
Other covariates adjusted for in the analysis included: age at diagnosis calculated by subtracting date of 
diagnosis from date of birth; age at clinic visit calculated by subtracting date of clinic visit from date of 
birth; duration of diabetes calculated in months by subtracting the date at first visit in the audit year from 
the date of diagnosis of Type 1 diabetes; which of the three Paediatric Diabetes clinics the child attended; 
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and pH levels recorded at diagnosis - used as an indicator of diabetic ketoacidosis severity at presentation, 
measured in a subgroup of patients.  
 
Statistical analysis 
 
Baseline characteristics were compared across all ethnic groups. Categorical variables were compared as 
frequencies using Chi2 or Fisher’s Exact test. Mean differences in continuous variables by ethnicity were 
analysed using simple linear regression.  
 
Stabilisation of glycaemic control during the first six months post-diagnosis was assessed using linear 
longitudinal mixed effects models, which allow comparison of population average HbA1c levels and change 
over time for the different ethnic categories while controlling for potential covariates. We approximated 
time trends using a quadratic model for time since diagnosis as this provided a better statistical fit than a 
linear model. Ethnicity, SES, age at diagnosis, sex and diabetes clinic were entered as time-constant 
predictors. We constructed a series of models using the xtmixed commands in Stata 13. The first model 
(Model 1) was an unadjusted growth model using time since diagnosis (disease duration) as the temporal 
metric. Subsequent models were additionally adjusted for our hypothesised predictors; sex and age at 
diagnosis in years (Model 2), ethnicity (Model 3), SES (Model 4) and diabetes clinic (Model 5). We tested for 
a potential interaction between ethnicity and duration to assess whether HbA1c trajectories differed by 
ethnic group.  We estimated all model parameters by maximum likelihood. We used generalised likelihood 
ratio statistics, -2 log-likelihood (-2LL), Aikake information criterion (AIC) and sample-adjusted Bayesian 
information criterion (BIC) to compare model fit between subsequent nested models, and Wald statistics to 
test hypotheses about model parameters. We plotted quadratic growth curves at the group level (i.e. 
ethnicity) to visualise the fit of the model. All analysis were run in Stata 13 (College Station, Texas). 
 
We ran models 3 and 5 above in a subgroup of patients with data on pH levels at diagnosis to assess any 
change to the observed ethnicity – HbA1c associations. 
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 Results 
 
Of the 571 subjects eligible to be included, 89 did not have any recorded data during the first six months 
post-diagnosis. Additionally, 39 had missing data on HbA1c during the first six months post-diagnosis 
leaving 443 (78% of the eligible population) children with 1,028 measurements of HbA1c during the first six 
months and data on all covariates that were included in the analysis. The mean number of HbA1c 
measurements per child during the first six months was 2.3 (range 1 to 7). 
 
Characteristics of the study population at baseline and six months post-diagnosis 
 
50% of the study population were female. Mean HbA1c at diagnosis of T1D was 93.7mmol/mol. All ethnic 
groups had relatively high HbA1c levels at diagnosis with the highest mean levels observed in Bangladeshi 
children (99.9mmol/mol (SD 24.1), Table 1). Mean deprivation score and the proportion of subjects in the 
lowest SES quartile (i.e. the most deprived) differed significantly by ethnic group, with the African-Somali, 
mixed and Black groups having the lowest mean deprivation scores and largest proportions of CYP in the 
most deprived SES quartile (Table 1). There were no significant differences in HbA1c at diagnosis by SES 
quartiles. We observed no significant differences in gender, age at diagnosis and pH by ethnicity. HbA1c 
decreased by an average of 32.4mmol/mol during the first six months post-diagnosis.  
 
Longitudinal modelling of HbA1c trajectories 
 
Table 2 shows the regression parameters from longitudinal modelling. We detected a significant difference 
in HbA1c when comparing ethnic minority children to White children. All ethnic minority groups had higher 
mean HbA1c levels at diagnosis compared to the White group. However, differences were statistically 
significant only in the Bangladeshi (9.1mmol/mol, 95%CI 4.5-13.6) and Asian-other (5.8mmol/mol, 2.3-9.4, 
Table 2) groups which exhibited the largest mean differences in HbA1c levels at diagnosis compared to 
White children. Adjustment for SES slightly enlarged the estimates for all ethnic groups, and the estimate 
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for the African-Somali group reached statistical significance (5.2mmol/mol, 0.1-10.2, Table 2). However, 
SES, age at diagnosis and gender were not significantly associated with HbA1c levels at diagnosis. We also 
observed a significant difference in HbA1c at diagnosis by diabetes clinic.  
All ethnic groups experienced an initial decrease in HbA1c levels during the first four months post-diagnosis 
followed by a slight gradual increase between months four and six, with a significant quadratic term in all 
models (Figure 1, Table 2). HbA1c levels decreased by an average 19.5mmol/mol during the first month 
after diagnosis for the entire group. Likelihood ratio tests showed that each subsequent model had a 
statistically better fit than the preceding model with fewer covariates. Model 5 with all covariates had the 
best fit (-2LL=8634 and AIC=8673, Table 3). In the final Model 5 with all covariates, 76% of the variation in 
HbA1c was due to individual differences, Intra-class Coefficient, ICC = 0.76, Table 2). 
The model testing for an interaction between ethnicity and duration found no statistically significant 
interaction, indicating no evidence of a difference by ethnicity in post-diagnosis HbA1c trajectories over 
time (data not shown).  
 
Multilevel modelling for change in HbA1c  with pH at diagnosis 
 
Models on pH at diagnosis and HbA1c were restricted to a smaller sample of 338 children with 764 HbA1c 
datapoints (average 2.3 HbA1c datapoints per subject, range 1 to 6) as pH at diagnosis was not documented 
in all cases. 
All ethnic minorities had higher mean HbA1c at diagnosis compared to White children as observed in 
models comprising the entire study sample (N=443). However, estimates for the mixed and Black groups 
previously not significant were observed to be significantly different from the White group. pH at diagnosis 
was inversely associated with HbA1c at diagnosis. For every one unit increase in pH levels (for e.g. from 7.2 
to 7.3), HbA1c decreased by an adjusted average of -15.6mmol/mol (-25.1, -6.2, Table 3).    
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Discussion 
 
Our aim was to analyse glycaemic control (HbA1c) during the first six months after diagnosis using 
longitudinal modelling to determine whether HbA1c trajectories differed by ethnicity. As expected, we 
observed a general and rapid improvement in HbA1c levels for the entire study sample that reached a nadir 
around four months post-diagnosis. This was followed by a slight gradual increase in HbA1c levels between 
four and six months post-diagnosis. We found that all ethnic minority children presented with poorer 
HbA1c at diagnosis compared to White children and the magnitude of this difference did not change over 
the study period. An additional aim was to assess the effect of pH (a marker of disease severity at 
diagnosis) on glycaemic control during the first six months after diagnosis. We found that while pH at 
diagnosis was negatively associated with HbA1c during the first month post-diagnosis, it did not affect the 
observed ethnicity-HbA1c growth trajectories.  
 
Comparisons with the literature: 
Few studies and none from the UK have investigated early glycaemic control (control during the first year 
after diagnosis) using longitudinal data from diagnosis onwards. Most did not investigate the impact of 
ethnicity on early glycaemic control, did not use advanced methods to analyse longitudinal data (such as 
mixed effects models) or had longer follow-up periods without focussing on the transient remission 
(‘honeymoon phase’) period as in this study. Our finding of initial very high HbA1c levels at diagnosis, 
followed by a steep decline is reported in other studies with comparable study populations (age at 
diagnosis and proportion of female subjects). However, those studies that reported HbA1c levels at 
diagnosis and during the first year post-diagnosis (including datapoints at six months post-diagnosis) did 
not investigate trends in glycaemic control and were restricted to study populations of White ethnicity 
limiting comparisons (9, 12-14). Chase et al found a steep decline in HbA1c levels at 2-4 months followed by 
a gradual increase similar to our findings (15). Studies that analysed data using longitudinal modelling with 
a focus on ethnic differences in metabolic control had a much longer follow-up and thus did not report 
exclusively on the first six months post-diagnosis when most patients undergo transient remission (16, 17). 
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Initial high HbA1c levels at diagnosis and lower levels at six months reported elsewhere are similar to that 
observed in our study.  
There have been conflicting reports on the association of age at diagnosis and gender with HbA1c levels at 
diagnosis and during follow-up. Some studies report that females and older children have increased HbA1c 
levels at diagnosis and during follow-up, whereas others show an interaction between gender and age at 
diagnosis on subsequent HbA1c levels during the first year post-diagnosis (12, 14, 17). We observed no 
association between either gender or age at diagnosis with initial and subsequent HbA1c levels.  
 
Strengths and limitations: 
We used a well powered sample and methods allowed inclusion of a large number of longitudinal 
datapoints. The study sample was drawn from East London where the majority (67%) belonged to an ethnic 
minority. This enabled us to study for the first time, paediatric glycaemic control in specific ethnic minority 
groups such as the Bangladeshi and Somali groups. Such vulnerable groups often get overlooked as they are 
analysed in combination with other ethnic groups masking potential underlying differences. Ethnicity was 
self-identified which is considered to be the ‘gold standard’ in studies on ethnicity and health (18).  
 
Our study also has certain limitations. The study sample was drawn from three paediatric diabetes clinics 
which operate together as a network since 2012 and results may not be generalizable to the rest of the 
country. However, we feel results can be generalised to ethnically diverse urban populations in other parts 
of the UK. One cannot exclude the possibility of residual confounding due to other factors known to impact 
on glycaemic control at diagnosis and during early follow-up which may interact with ethnicity including 
family structure, family history of diabetes, pubertal status and incidence of severe hypoglycaemia and 
diabetic ketoacidosis.  Our finding of no association between SES and metabolic control at diagnosis was 
unexpected. This could be explained by the fact that a significant proportion of the study sample was highly 
deprived (reflecting the neighbourhood from which the sample was drawn) leading to low variability in SES. 
Black and mixed ethnic children have increased risk for poor metabolic control (4). However, the 
statistically nonsignificant estimates for both groups, while in the right direction, could be due to low 
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statistical power. We were unable to calculate the proportion of subjects undergoing remission at different 
time points by known methods as we lacked the information needed (insulin dose-adjusted HbA1c or total 
daily insulin dose/kg body weight/day).  
 
Several factors may explain the observed ethnic differences in metabolic control at diagnosis and during 
early follow-up including physiological (greater loss of insulin producing beta cells in some ethnic groups 
and greater disease severity at diagnosis) and psychosocial (later presentation at diagnosis, attitudes 
towards understanding disease symptoms and seeking care at later stages) factors. Studies indicate that 
younger children often present with greater acidosis, experience a more rapid loss of insulin producing β-
cells and worse symptoms at diagnosis (19). However, we found no differences in age at diagnosis by 
ethnicity that could explain the observed differences in HbA1c at diagnosis.  
 
Our outcomes are timely given long term data from the Diabetes Control and Complications 
Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDC) recently reported by Orchard 
and colleagues (20).  During 30 years of follow-up, less cardiovascular disease events occurred in the former 
intensive treatment group subjects compared with the former conventional treatment group subjects. The 
lower HbA1c levels during the DCCT/EDIC, achieved through intensive insulin therapy, statistically account 
for all of the observed treatment effect on cardiovascular disease risk. Whilst similar long term data are 
required for childhood onset T1D, the DCCT/EDC outcomes indicate that achieving very early target HbA1c 
has important benefits in later life. The mechanisms for the ethnic differences observed in our study 
require further investigation.      
 
Conclusions: 
Ethnic minority children with type 1 diabetes presented with worse glycaemic control (higher mean HbA1c 
levels) at diagnosis compared to White children. These differences by ethnicity were sustained throughout 
the study period including the ‘honeymoon’ phase when all groups experienced a steep decline in HbA1c 
levels. Our study highlights the importance for formulating interventions early on, at the time of diagnosis 
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and during the first few months to ensure that differences in glycaemic control are reduced. This is 
especially important as people with poor early glycaemic control are more likely to have poor control later 
in life.   
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Table 1. Characteristics of the study population (N=443) diagnosed with type 1 diabetes between 1 Jan 2005 and 31 Dec 2015. Values are means (standard 
deviations) or proportions. 
  
Ethnic group 
Characteristics 
N (%) 
White 
164 (37) 
Mixed 
37 (8) 
Black 
60 (14) 
African-Somali 
39 (9) 
Bangladeshi 
45 (10) 
Asian-Other 
98 (22) 
Total 
443 (100) 
p Valuea 
Girls (%) 46 38 47 54 64 55 50 0.14 
Age at diagnosis 
(years) 
9.1 (4.5) 7.7 (4.0) 9.2 (3.9) 7.7 (4.2) 9.3 (4.2) 9.1 (4.6) 8.9 (4.4) 0.2 
HbA1c at diagnosis 
(mmol/mol)b 
92.1 (20.8) 88.8 (22.1) 95.2 (25.4) 91.8 (21.6) 99.9 (24.1) 93.2 (32.5) 93.7 (24.1) 0.62 
HbA1c at 6 months 
(mmol/mol)c 
58.9 (14.1) 60.8 (14.7) 68.1 (26.1) 64.7 (16.9) 61.2 (19.5) 60.4 (17.9) 61.3 (17.9) 0.15 
Mean difference in 
HbA1c  between 
diagnosis and 6 
months (mmol/mol) 
33.2 28 27.1 27.1 38.7 32.8 32.4  
 
pH at diagnosisd 
7.58 (0.173) 7.271 (0.146) 7.270 (0.152) 7.311 (0.150) 7.296 (0.154) 7.272 (0.163) 7.272 (0.161) 0.68 
Index of multiple 
deprivation  score 
10537 (7303) 5973 (3588) 6166 (3953) 5035 (2911)  6855 (5324) 8665 (5178) 8291 (6029) <0.001 
Index of multiple 
deprivation  score 
(median) 
8720 5094 5023 4950 5554 7574 6743  
Proportion in lowest 
quartile  
18 38 38 49 36 20 28 <0.001 
Number of clinic visits  2.6 (1.3) 2.8 (1.6) 2.7 (1.5) 2.5 (1.3) 2.6 (1.3) 2.9 (1.7) 2.7 (1.5) 0.11 
aTest for difference in means or proportions b202 HbA1c values recorded during the first one month post-diagnosis  c285 HbA1c values recorded between the 5th  
and 6th months post-diagnosis. dSmaller sample, N=338
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Table 2. Multilevel model for change in HbA1c during the first six months post-diagnosis 
Covariates Model1: Growth 
Model 
Model 2: Plus age 
at diagnosis 
Model 3: Plus 
Ethnicity 
Model 4: Plus 
Socioeconomic 
Status 
Model 5: Plus 
Paediatric diabetes 
clinic 
Fixed effects      
Constant/intercept  95.1    (92.4, 97.7) 97. 9    (92.5, 103.4) 93.5     (87.8, 99.3) 91.1     (84.9, 97.2) 90.4   (84.3, 96.5) 
      
Duration  Linear -19.6  (-21.1, -18.1) -19.6  (-21.1, -18.1) -19.6  (-21.1, -18.1) -19.6   (-21.1, -18.1) -19.6 (-21.2, -18.1) 
                  Quadratic  2.4    (2.2, 2.7)  2.4     (2.2, 2.7)   2.4    (2.2, 2.7) 2.4       (2.2, 2.7) 2.4     (2.2, 2.7) 
      
Sex            Male  Ref Ref Ref Ref 
                  Female  -2.5     (-5.2, 0.1) -1.9     (-4.6, 0.7) -1.9     (-4.5, 0.7) -1.9    (-4.5, 0.7) 
      
Age at diagnosis  0.1      (-0.2, 0.4) 0.1      (-0.2, 0.4) 0.1       (-0.2, 0.4) 0.1      (-0.3, 0.3) 
      
Ethnicity      
                 White   Ref Ref Ref 
                 Mixed   4.1       (-0.9, 9.1) 4.6       (-0.4, 9.7) 3.9     (-1.0, 8.9) 
                   Black   3.3       (-0.9, 7.4) 3.7       (-0.5, 8.0) 4.0     (-0.1, 8.1) 
  African-Somali   4.1       (-0.8, 9.1) 5.1       (0.1, 10.1) 4.5     (-0.5, 9.4) 
      Bangladeshi   8.8       (4.3, 13.3) 9.3       (4.7, 14.0) 9.4     (4.8, 13.9) 
       Asian-Other   5.8       (2.3, 9.4) 5.7       (2.2, 9.3) 3.9     (0.2, 7.6) 
      
Socioeconomic 
status 
     
Quartile 1 (poorest)    Ref Ref 
Quartile 2    3.2       (-0.3, 6.7) 2.6     (-0.8, 6.1) 
Quartile 3    3.9       (0.2, 7.6) 2.5     (-1.1, 6.3) 
Quartile 4 (richest)    2.5       (-1.5, 6.5) 2.7     (-1.3, 6.7) 
      
Paediatric Diabetes 
Clinic 
     
Clinic 1     Ref 
Clinic 2     1.7     (-2.1, 5.4) 
Clinic 3     6.1     (2.8, 9.3) 
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Interclass 
Correlation (ICC) 
0.77 0.77 0.76 0.76 0.76 
Goodness of fit      
Aikake information 
criterion (AIC) 
8690.614     8690.926    8682.079    
 
8683.001    8673.485 
Bayesian 
information 
criterion (BIC) 
8725.161 8735.345 8751.175 8766.902 8767.257 
-2LL 8676 8672 8654 8648 8635 
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Table 3. Multilevel model for change in HbA1c during the first six months post-diagnosis adjusted for pH 
levels at diagnosis 
Covariates Model 1 Model 2:  
   
Fixed effects   
Constant/intercept  202.1   (134.2, 270.9) 203.7   (136.4, 271.1) 
   
Duration  Linear -20.6  (-22.5, -18.8) -20.8   (-22.6, -18.9) 
                  Quadratic   2.5    (2.3, 2.8) 2.6       (2.3, 2.8) 
   
Sex            Male Ref Ref 
                  Female -0.5     (-3.5, 2.5) -0.4     (-3.3, 2.6) 
   
Age at diagnosis 0.1      (-0.2, 0.5) 0.1       (-0.3, 0.4) 
   
pH at diagnosis -15.2 (-24.7, -5.7) -15.7 (-25.1, -6.3) 
   
Ethnicity   
                 White Ref Ref 
                 Mixed 7.1       (1.7, 12.6) 6.5       (1.1, 11.9) 
                   Black 4.2       (0.2, 8.8) 4.6       (0.9, 9.1) 
  African-Somali 4.7       (-0.9, 10.3) 5.2       (-0.4, 10.9) 
      Bangladeshi 10.1     (4.9, 15.3) 10.6     (5.4, 15.7) 
       Asian-Other 7.5       (3.4, 11.5) 5.3       (1.8, 9.4) 
   
Socioeconomic 
status 
  
Quartile 1 (poorest)   
Quartile 2  2.2     (-1.7, 6.1) 
Quartile 3  1.9     (-2.1, 5.9) 
Quartile 4 (richest)  2.7     (-1.9, 7.3) 
   
Paediatric Diabetes 
Clinic 
  
Clinic 1  Ref 
Clinic 2  1.9   (-2.5, 6.3) 
Clinic 3  6.1    (2.4, 9.6) 
Goodness of fit   
Aikake information 
criterion (AIC) 
6434.644 6430.969 
Bayesian 
information 
criterion (BIC) 
6504.184 6523.688 
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Figure 1. Predicted glycaemic control (HbA1c) trajectories during the first six months post-diagnosis by 
ethnicity.  
 
Trajectories are estimated for a sample group with a mean age of diagnosis = 9 years and IMD = quartile 3. 
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